Differential aspects of Solcoderm therapy as a function of dermatologic diagnoses.
Experience with 265 Solcoderm-treated lesions in 131 patients followed for 1 year is the basis of delineating the preferred methods of treating skin tumors with this new caustic agent. General principles and diagnosis-specific suggestions are presented.